Éric Bruckert

43.9k total citations · 9 hit papers
384 papers, 17.7k citations indexed

About

Éric Bruckert is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Éric Bruckert has authored 384 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 217 papers in Surgery, 141 papers in Endocrinology, Diabetes and Metabolism and 78 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Éric Bruckert's work include Lipoproteins and Cardiovascular Health (185 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (94 papers) and Cancer, Lipids, and Metabolism (46 papers). Éric Bruckert is often cited by papers focused on Lipoproteins and Cardiovascular Health (185 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (94 papers) and Cancer, Lipids, and Metabolism (46 papers). Éric Bruckert collaborates with scholars based in France, United States and Italy. Éric Bruckert's co-authors include Philippe Giral, Thierry Poynard, Vlad Ratziu, G Turpin, Frédéric Charlotte, S. Dejager, Bernard Hainque, M. John Chapman, André Grimaldi and Claude Jardel and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Éric Bruckert

363 papers receiving 17.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

2005 1.6k citations Philippe Giral, Éric Bruckert et al. profile →
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

2005 926 citations Éric Bruckert, S. Dejager et al. profile →
Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss*

2000 837 citations Jean‐Philippe Bastard, Claude Jardel et al. The Journal of Clinical Endocrinology & Metabolism profile →
Liver fibrosis in overweight patients

2000 786 citations Philippe Giral, Éric Bruckert et al. profile →
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

2008 503 citations Philippe Giral, Éric Bruckert et al. profile →
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

2014 421 citations Éric Bruckert et al. profile →
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

2019 416 citations Joseph L. Witztum, Daniel Gaudet et al. profile →
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance

2016 354 citations Éric Bruckert et al. profile →
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

2015 345 citations Éric Bruckert et al. Journal of clinical lipidology profile →

Peers

Countries citing papers authored by Éric Bruckert

Since Specialization

Citations

This map shows the geographic impact of Éric Bruckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Bruckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Bruckert more than expected).

Fields of papers citing papers by Éric Bruckert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Bruckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Bruckert. The network helps show where Éric Bruckert may publish in the future.

Co-authorship network of co-authors of Éric Bruckert

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Bruckert. A scholar is included among the top collaborators of Éric Bruckert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Bruckert. Éric Bruckert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management of lipid variables in primary cardiovascular prevention: A position paper from the Heart, Vessels and Metabolism Group of the French Society of Cardiology 2024 ·Archives of cardiovascular diseases ·François Diévart, Éric Bruckert, Victor Aboyans, (unknown), Franck Boccara, (unknown), Joseph Emmerich, Michel Farnier, Antonio Gallo, Gilles Lemesle, François Paillard, François Schiele, Serge Kownator	1
2	Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia 2024 ·Arteriosclerosis Thrombosis and Vascular Biology ·Sophie Béliard, Samir Saheb, (unknown), (unknown), René Valéro, Éric Bruckert, Michel Farnier, Antonio Gallo	8
3	Transcriptomic profile helps to identify high-risk heterozygous familial hypercholesterolemia patients 2023 ·Archives of cardiovascular diseases ·(unknown), Valérie Carreau, Maryse Guérin, Éric Frisdal, Philippe Lesnik, (unknown), Philippe Giral, Olivier Bluteau, M. Georget, Randa Bittar, Dominique Bonnefont‐Rousselot, Éric Bruckert, Alban Redheuil, Alain Carrié, Wilfried Le Goff, Antonio Gallo	1
4	Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial 2022 ·Stroke ·Pierre Amarenco, Yong‐Jae Kim, Julien Labreuche, Hubert Charles, Maurice Giroud, Byung‐Chul Lee, Philippa C. Lavallée, Marie‐Hélène Mahagne, Elena Meseguer, Norbert Nighoghossian, Philippe Gabríel Steg, Éric Vicaut, Éric Bruckert, Olivier Godefroy	14
5	The position of functional foods and supplements with a serum LDL-C lowering effect in the spectrum ranging from universal to care-related CVD risk management 2020 ·Atherosclerosis ·Sabine Baumgartner, Éric Bruckert, Antonio Gallo, Jogchum Plat	44
6	Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles 2019 ·Journal of the Endocrine Society ·Louis O’Dea, James E. MacDougall, Veronica J. Alexander, Andrés Digenio, (unknown), Marcello Arca, Patrick M. Moriarty, John J.P. Kastelein, Éric Bruckert, Handrean Soran, Joseph L. Witztum, Robert A. Hegele, Daniel Gaudet	42
7	The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion 2019 ·Atherosclerosis Supplements ·Maciej Banach, Éric Bruckert, Olivier Descamps, Lars Ellegård, М. В. Ежов, Bernhard Föger, Zlatko Fras, Petri T. Kovanen, Gustavs Latkovskis, Winfried März, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Angela Pirillo, Andrea Poli, Željko Reiner, Günther Silbernagel, Margus Viigimaa, Michal Vráblík, Alberico L. Catapano	39
8	New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia 2018 ·Scientific Reports ·Sandy Elbitar, Delia Susan‐Resiga, Youmna Ghaleb, Petra El Khoury, Gina M. Peloso, Nathan O. Stitziel, Jean‐Pierre Rabès, Valérie Carreau, Josée Hamelin, (unknown), Éric Bruckert, Cathérine Boileau, Nabil G. Seidah, Mathilde Varret, Marianne Abifadel	25
9	Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia 2017 ·Journal of clinical lipidology ·Antonio Gallo, Philippe Giral, Alain Carrié, Valérie Carreau, Sophie Béliard, Randa Bittar, Marianna Maranghi, Marcello Arca, Philippe Cluzel, Alban Redheuil, Éric Bruckert, David Rosenbaum	30
10	Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels 2016 ·Journal of clinical lipidology ·Boris Hansel, Dominique Bonnefont‐Rousselot, Alexina Orsoni, Randa Bittar, Philippe Giral, Ronan Roussel, Michel Marre, Kamel Mohammedi, Éric Bruckert, (unknown), Anatol Kontush	11
11	Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders 2013 ·PLoS ONE ·Jihane Pakradouni, Wilfried Le Goff, Claire Calmel, Bénédicte Antoine, Elise F. Villard, Éric Frisdal, Marianne Abifadel, Joan Tordjman, Christine Poitou, Dominique Bonnefont‐Rousselot, Randa Bittar, Éric Bruckert, Karine Clément, Bruno Fève, Cécile Martinerie, Maryse Guérin	45
12	[Prevalence of sleep apnea in men with metabolic syndrome and controlled hypertension]. 2007 ·PubMed ·(unknown), Fleur Cohen‐Aubart, (unknown), P. Giral, Éric Bruckert, Xavier Girerd	6
13	Hypothyroïdie et risque cardiovasculaire : principaux messages pour le clinicien 2005 ·Sang thrombose vaisseaux ·(unknown), Mathieu Gautier, Christel Jublanc, Éric Bruckert	0
14	Hypercholestérolémies monogéniques de l’enfant : stratégies thérapeutiques 2005 ·Sang thrombose vaisseaux ·Valérie Carreau, Jean‐Philippe Girardet, Éric Bruckert	0
15	Adipose Tissue IL-6 Content Correlates with Resistance to Insulin Activation of Glucose Uptake both in Vivo and in Vitro 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Jean‐Philippe Bastard, Mustapha Maachi, Jeanne Tran Van Nhieu, Claude Jardel, Éric Bruckert, André Grimaldi, Jean‐Jacques Robert, Jacqueline Capeau, Bernard Hainque	472
16	Variations nycthémérales et interindividuelles de la synthèse du cholestérol 2001 ·Sang thrombose vaisseaux ·Wilfried Le Goff, (unknown), John Chapman, Éric Bruckert	1
17	Les phytostérols : une nouvelle approche diététique de l’hypercholestérolémie 2000 ·Sang thrombose vaisseaux ·Fabienne Nigon, (unknown), (unknown), (unknown), John Chapman, Éric Bruckert	2
18	[Impact of an information campaign on cardiovascular risk factors. 5-year results at the study town Epernon]. 1999 ·PubMed ·Éric Bruckert, (unknown), (unknown), Patrick Blin, (unknown), (unknown)	5
19	A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition 1992 ·Metabolism ·Jean‐Marie Bard, H J Parra, (unknown), (unknown), Olivier Ziegler, C. Dachet, Éric Bruckert, P Douste‐Blazy, Pierre Drouin, B Jacotot, J. L. de Gennes, Ulrich Keller, Jean‐Charles Fruchart	67
20	Hétérogénéité des lipoprotéines de basse densité (LDL) et athérosclérose 1990 ·Annales de biologie clinique ·S. Dejager, (unknown), Éric Bruckert	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact